The influence of CCPA and RF on the five-year outcomes in patients with early rheumatoid arthritisиве

Автор: Ermakova Yu.A., Karateev D.E., Luchikhina E.L., Demidova N.V.

Журнал: Саратовский научно-медицинский журнал @ssmj

Рубрика: Внутренние болезни

Статья в выпуске: 2 т.11, 2015 года.

Бесплатный доступ

Objective: to study the influence of CCPA and RF on 5-year outcomes in patients with early rheumatoid arthritis (RA). Subjects and methods. 204 patients with early RA (0,05. Between RF (+) (n=138) and RF (-) (n=66) groups we did not find differences (p>0,05). Radiological damage in the CCPA(+) patients was more pronounced from the second year of the observation. Baseline, after 1 year SHS (M±o) was 19,7±10,5 (compared 15,1±8,9), 25,4±16,8 (20,3±12,2), p>0,05. From 2 to 5 years — 33,5±20,8 (25,3±14,2), 40,8±26,8 (31,9±20,2), 48,0±28,8 (37,2±22,6), 55,6±30,5 (44,0±24,5), respectively, p

Genetically engineered biological agents, rheumatoid artritis, ccpa- and rf-positive patients

Короткий адрес: https://sciup.org/14918104

IDR: 14918104

Статья научная